Aggredyne
US-based Aggredyne Inc. develops biomedical diagnostics and markets platelet response tests to healthcare providers.
Founded
2011US-based Aggredyne Inc. develops biomedical diagnostics and markets platelet response tests to healthcare providers.
Founded in Houston, Aggredyne Inc. is a biomedical diagnostics company focused on enhancing patient care through on-demand platelet function testing. Their core mission is to improve the management of anti-platelet therapy by providing accurate, reliable, and cost-effective diagnostic tools. The company's flagship product, the AggreGuide A-, utilizes patented light scattering technology to measure platelet stickiness, offering a simple and low-cost solution for assessing platelet function. Aggredyne primarily markets its innovative products to physicians and clinics across the United States.
Aggredyne has garnered attention for its cutting-edge technology and significant contributions to the medical diagnostics field. The company's notable achievements include the successful development and commercialization of their platelet aggregometer, which has been well-received by healthcare providers for its precision and ease of use. While specific investors and affiliated individuals are not detailed, Aggredyne's impact is evident in its growing presence and adoption within the healthcare industry, underscoring its role in advancing patient care through improved diagnostic capabilities.
Companies similar to Aggredyne include ThromboVision, Aggamin, Abram Scientific and Stasys.
Aggredyne was founded in 2011.
Aggredyne's headquarters is located in Houston, TX, US.
Aggredyne's most recent funding round was for $3M (USD) in April 2012.
As of Apr 23, 2012, Aggredyne has disclosed funding of $3M (USD). Undisclosed round amounts are excluded.
Aggredyne has 75 employees as of Feb 5, 2024.
